Former heavyweight champion Joseph Parker has maintained that the positive drug test which led to his provisional suspension was not the result of his own actions, but rather the consequence of exposure to cocaine used by his personal nutritionist. The claim, which was relayed to the UK Anti-Doping (UKAD) agency, forms the core of a complex case that has now reached a resolution, allowing Parker to return to competition. The incident originated after Parker’s unexpected loss to Britain’s Fabio Wardley on 25 October 2025 in London.
In the days that followed, a routine anti‑doping analysis conducted by UKAD detected benzoylecgonine, the primary metabolite of cocaine, in Parker’s urine sample. This finding, known in anti‑doping parlance as an adverse analytical finding (AAF), triggered a provisional ban that could have extended up to two years. Parker has consistently denied any personal use of prohibited substances. On Wednesday, he announced that the suspension had been lifted and that he intended to step back into the ring in the near future.
The following day, UKAD issued an official statement confirming that Parker was cleared to resume his boxing career, and it provided a detailed account of the evidence he supplied. According to the UKAD release, on 6 March 2026 Parker submitted documentation asserting that the AAF stemmed from inadvertent exposure to cocaine through his nutritionist. The nutritionist, who had been employed by Parker to prepare for the Wardley bout, reportedly confessed to being a regular cocaine user and admitted to daily consumption in the week leading up to the fight.
Parker’s statement further noted that he had first engaged this nutritionist in April 2023, establishing a timeline for the alleged contamination. UKAD’s investigative process involved several follow‑up requests. Between 14 April and 3 June 2026, the agency asked Parker for additional information to substantiate his claim.
The organization also consulted an independent scientific expert to evaluate the likelihood that the cocaine metabolite entered Parker’s system outside of competition. The expert concluded that the ingestion most probably occurred before the competition window—specifically before 11:59 p.m. on 24 October 2025—and therefore was unrelated to Parker’s athletic performance.
On the basis of this opinion, UKAD decided to lift the provisional suspension on 22 June 2026 and to impose a three‑month period of ineligibility that was deemed already served. This sanction satisfied the anti‑doping rule violation without extending Parker’s ban. In its scientific assessment, the expert acknowledged two plausible routes for the contamination. First, the nutritionist might have unintentionally introduced cocaine into food or supplements that Parker consumed, leading to trace amounts of benzoylecgonine in his urine.
Second, although less likely, the expert could not completely rule out the possibility that Parker had been exposed to a larger, pharmacologically active dose of cocaine, with the detected metabolite representing the tail end of that exposure. The ramifications of the case extend beyond the doping issue. The result of Parker’s fight with Wardley, originally recorded as an 11th‑round stoppage victory for the British boxer, has now been altered to a disqualification loss for Parker.
This adjustment reflects the anti‑doping violation rather than a knockout defeat. Parker’s career trajectory adds further context to the controversy. After losing his world title to Anthony Joshua in 2018, Parker experienced a mixed run of results. A heavy defeat to Joe Joyce in 2022 was followed by a six‑fight winning streak that featured high‑profile victories over Deontay Wilder and Zhilei Zhang, as well as the acquisition of the WBO interim heavyweight belt.
He was slated to challenge IBF champion Daniel Dubois in February 2025, but Dubois withdrew due to illness shortly before the fight. Choosing to fight Wardley was a strategic gamble. By taking the bout, Parker risked his standing as the WBO mandatory challenger to undisputed champion Oleksandr Usyk, hoping a win would catapult him back into title contention. The loss, compounded by the doping allegation, temporarily derailed those plans.
Now, with the anti‑doping matter resolved, Parker is positioned to rebuild his standing. The three‑month sanction, already served, means he can train, compete, and pursue another title opportunity without further delay.
Whether he will seek a rematch with Wardley, aim for a clash with Usyk, or target another contender remains to be seen, but the clearance from UKAD restores his eligibility to fight at the highest level. The case also underscores the broader issue of athlete support staff and the potential for inadvertent doping violations.
Nutritionists, trainers, and other personnel wield significant influence over an athlete’s intake, and their personal habits can inadvertently expose athletes to prohibited substances. Anti‑doping agencies are increasingly emphasizing the importance of thorough vetting and education of support teams to prevent similar incidents. In summary, Joseph Parker’s positive cocaine test has been attributed to contamination from his nutritionist’s cocaine use, a claim supported by an independent scientific opinion that the exposure occurred out of competition.
UKAD’s decision to lift his provisional suspension and to count a three‑month ineligibility period as served clears the path for Parker to re‑enter the heavyweight division and continue his pursuit of world‑title glory.